| Implementing pharmacogenomics in Europe: design and implementation strategy of the ubiquitous pharmacogenomics consortium CH van der Wouden, A Cambon‐Thomsen, E Cecchin, KC Cheung, ... Clinical Pharmacology & Therapeutics 101 (3), 341-358, 2017 | 299 | 2017 |
| A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study JJ Swen, CH van der Wouden, LEN Manson, H Abdullah-Koolmees, ... The Lancet 401 (10374), 347-356, 2023 | 224 | 2023 |
| A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics C Mizzi, E Dalabira, J Kumuthini, N Dzimiri, I Balogh, N Başak, R Böhm, ... PloS one 11 (9), e0162866, 2016 | 117 | 2016 |
| Personalized pharmacogenomics profiling using whole-genome sequencing C Mizzi, B Peters, C Mitropoulou, K Mitropoulos, T Katsila, MR Agarwal, ... Pharmacogenomics 15 (9), 1223-1234, 2014 | 107 | 2014 |
| Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece Y Mai, C Mitropoulou, XE Papadopoulou, A Vozikis, DN Cooper, ... Personalized Medicine 11 (1), 15-26, 2014 | 58 | 2014 |
| Economic evaluation of pharmacogenomics: a value-based approach to pragmatic decision making in the face of complexity SR Snyder, C Mitropoulou, GP Patrinos, MS Williams Public Health Genomics 17 (5-6), 256-264, 2014 | 57 | 2014 |
| Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke C Mitropoulou, V Fragoulakis, N Bozina, A Vozikis, S Supe, T Bozina, ... Pharmacogenomics 16 (2), 137-148, 2015 | 49 | 2015 |
| Estimating the effectiveness of DPYD genotyping in Italian individuals suffering from cancer based on the cost of chemotherapy-induced toxicity V Fragoulakis, R Roncato, C Dalle Fratte, F Ecca, M Bartsakoulia, ... The American Journal of Human Genetics 104 (6), 1158-1168, 2019 | 47 | 2019 |
| Key challenges for next‐generation pharmacogenomics: Science & Society series on Science and Drugs K Kampourakis, E Vayena, C Mitropoulou, RH van Schaik, DN Cooper, ... EMBO reports 15 (5), 472-476, 2014 | 47 | 2014 |
| Economic evaluation in psychiatric pharmacogenomics: a systematic review K Karamperis, M Koromina, P Papantoniou, M Skokou, F Kanellakis, ... The pharmacogenomics journal 21 (4), 533-541, 2021 | 44 | 2021 |
| Test pricing and reimbursement in genomic medicine: towards a general strategy A Vozikis, DN Cooper, C Mitropoulou, ME Kambouris, A Brand, V Dolzan, ... Public Health Genomics 19 (6), 352-363, 2017 | 42 | 2017 |
| Locus‐specific database domain and data content analysis: evolution and content maturation toward clinical use a C Mitropoulou, AJ Webb, K Mitropoulos, AJ Brookes, GP Patrinos Human mutation 31 (10), 1109-1116, 2010 | 42 | 2010 |
| Integrating next-generation sequencing in the clinical pharmacogenomics workflow E Giannopoulou, T Katsila, C Mitropoulou, EE Tsermpini, GP Patrinos Frontiers in pharmacology 10, 384, 2019 | 36 | 2019 |
| Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study CH van der Wouden, S Böhringer, E Cecchin, KC Cheung, ... Pharmacogenetics and genomics 30 (6), 131-144, 2020 | 35 | 2020 |
| Stakeholder analysis in pharmacogenomics and genomic medicine in Greece C Mitropoulou, Y Mai, RH Van Schaik, A Vozikis, GP Patrinos Public Health Genomics 17 (5-6), 280-286, 2014 | 34 | 2014 |
| Application of economic evaluation to assess feasibility for reimbursement of genomic testing as part of personalized medicine interventions S Simeonidis, S Koutsilieri, A Vozikis, DN Cooper, C Mitropoulou, ... Frontiers in pharmacology 10, 830, 2019 | 32 | 2019 |
| Measuring the value of pharmacogenomics evidence GP Patrinos, C Mitropoulou Clinical Pharmacology & Therapeutics 102 (5), 739-741, 2017 | 30 | 2017 |
| Economic evaluation in genomic medicine V Fragoulakis, C Mitropoulou, M Williams, GP Patrinos Academic Press, 2015 | 30 | 2015 |
| Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention V Fragoulakis, M Bartsakoulia, X Díaz-Villamarín, K Chalikiopoulou, ... The Pharmacogenomics Journal 19 (5), 438-445, 2019 | 26 | 2019 |
| A brighter future for the implementation of pharmacogenomic testing CH van der Wouden, JJ Swen, M Samwald, C Mitropoulou, M Schwab, ... European Journal of Human Genetics 24 (12), 1658-1660, 2016 | 25 | 2016 |
